| BPMC Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BPMC market cap history going back to 6/10/2015:
Also see: BPMC Shares Outstanding History and BPMC YTD Return |
As of 4/29/2025 Blueprint Medicines has a market cap of 5.71 billion. Investors often follow the BPMC market cap history to compare the size of the company over time.
This page shows BPMC market capitalization trends over time, with 39 market cap datapoints presented, dating back to 6/10/2015.

| BPMC Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BPMC market cap history going back to 6/10/2015:
Also see: BPMC Shares Outstanding History and BPMC YTD Return |
| BPMC Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BPMC Historical Market Cap: +21.19% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BPMC Stock Price Chart |
| About Blueprint Medicines Corp |
| Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. Co. delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and GAVRETO (pralsetinib), to patients in the U.S. and Europe, and it is globally advancing multiple programs for systemic mastocytosis (SM), lung cancer, breast cancer and other genomically defined cancers, and cancer immunotherapy. We show 39 historical shares outstanding datapoints in our BPMC shares outstanding history coverage, used to compute BPMC market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BPMC market cap history over the course of time is important for investors interested in comparing BPMC's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BPMC versus a peer is one thing; comparing BPMC market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BPMC can fluctuate over the course of history. With this page we aim to empower investors researching BPMC by allowing them to research the BPMC market cap history. |
| BPMC Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| BPMC Share Performance |
| Market Cap Peers |
| Blueprint Medicines (BPMC) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
BPTH Market Cap History BRKR Market Cap History BRTX Market Cap History BSGM Market Cap History BSPM Market Cap History BSTC Market Cap History BSX Market Cap History BTAI Market Cap History BTCY Market Cap History BTSG Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.